Celector (R) innovation lies on its proprietary technology for tag-less separation and selection of cells, particularly human stem cells from complex, adult "discarded" tissues (e.g. placenta, umbilical cord, lipoaspirate, dental pulp). These cells are increasingly used for cell therapy applications in regenerative medicine. Celector(R) separates, profile, characterize, counts, isolate and collect best cells without manipulation. Celector(R) is relies on a robust management of IP based on a clusters of different national and international patents on its methods, technologies, and devices for the cell fractionation process.